the gastrointestinal tract and plasma of normal adults. Thus it is not truly tumour-specific. We have measured CEA using the radioimmunoassay of Egan et al. (1972) on account of its readier routine clinical applicability. Table 1 summarizes some of our results which are similar to those reported by other workers using different assay procedures (Moore et al. 1971 , Lo Gerfo et al. 1971 , Zamchek et al. 1972 . Approximately 70% of all gastrointestinal tumours yield above normal (> 12.5 ng/ml) values. However, 33 % of inflammatory conditions, in particular ulcerative colitis, Crohn's disease and peptic ulceration, can give false positive results. None the less, only malignant tumours result in plasma levels in excess of 40 ng/ml (Table 1) . Patients with other malignant tumours including those of mammary, bronchial, genitourinary and lymphoreticular origin, can also have elevated plasma CEA levels.
The incidence of positive results increases with tumour spread and this is illustrated by analysis of the data from colonic and rectal carcinomas (Table 2) ; only 45 % of early localized tumours are positive.
Successful and complete removal of tumours is associated most often with a decline of elevated values to normal within two to seven days postoperatively. This fall may be delayed for up to three to four weeks; occasionally, plasma CEA levels may rise in the immediate postoperative phase before declining. Recurrence or incomplete removal of tumours is generally associated with return or maintenance of raised plasma CEA levels respectively. Hence, CEA as measured by present methods, is not tumour specific and a negative result does not exclude the presence of a tumour. However, it seems to be a clinically useful test in association with other investigative parameters to assess the adequacy of surgery and the development of distance recurrences. Certainly a negative result excludes the presence of widespread metastatic disease. 
Uptake of Gallium-67 in Colonic and Rectal Tumours [Abstract]
A radioisotope of gallium was originally used to study the uptake of this element in bone tumours. An incidental finding in this original work was the concentration of gallium in lymph nodes involved by Hodgkin's disease. Since then a number of papers have demonstrated that gallium-67 can be used successfully in the diagnosis and follow up of patients with a variety of tumours.
In this study gallium-67 was used to evaluate early colonic carcinoma and assess the degree and distribution of uptake in various colonic and rectal tumours. A dose of 0.5 mCi e7Ga citrate was administered to 20 patients 24 hours prior to operation. Specimens taken at operation were assayed for radioactivity and it was found that the uptake varied from low concentration in benign lesions such as diverticulitis and polyps to relatively high concentrations in undifferentiated carcinomas. Several scans were carried out on patients who had a higher activity of gallium-67.
It was found that if the bowel was thoroughly prepared, fecal contamination was not a problem and the scan could be successfully used to demonstrate the extent of the tumour. It was concluded that gallium-67 was of some value in the preoperative diagnosis of colonic and rectal "Present address: Memorial Hospital for Cancer and Allied Diseases, New York, NY 10021, USA carcinoma but the difficulty of fecal excretion had to be surmounted. Further studies on the influence of blood flow are being pursued to help explain some of the variations in gallium uptake.
A full account of this work appears in the British MedicalJournal, 1972, Grading is a subjective assessment by the pathologist, based on cellular differentiation and arrangement. At St Mark's hospital approximately 60 % of rectal tumours are assessed as average, 20% as high and 20% as low grade. It is known that there is a definite relationship between grade of rectal tumour and prognosis (Dukes 1957) .
The records of all patients who had a rectal cancer removed at St Mark's Hospital in the years 1958-65 were reviewed to see whether definite beneficial results have followed operations whose choice was influenced by tumour grade.
Only high grade growths are considered. At St Mark's Hospital there has been a general reluctance to carry out restorative resection for these growths because of their known more extensive local spread and the high incidence of local recurrence. The majority of patients with high grade rectal cancer have had abdominoperineal excision. This seems rational until it is realized that the difference between excision and resection is only in downward extent, whereas the spread of cancer is in general upward.
An equally rational and perhaps less mutilating approach would be to decide on the operation of choice, irrespective of tumour grade, accepting that those tumours with extensive local spread are very advanced and will, despite surgery, kill the patient in the near future. For patients who are cured an unnecessary colostomy and the associated morbidity is avoided.
Results
Overall survival: There were 176 high grade rectal and rectosigmoid growths removed, 143 by excision, 33 by resection; many of the operations were palliative. Staging of these tumours by Dukes' classification was: A, 1 %; B, 8%; Cl, 57%; C2, 34%. There were 6 operative deaths among the 143 excisions (over twice the St Mark's figure for all rectal excisions), and none among the resections.
Two patients were lost to follow up, one in Saudi Arabia and the other in Greece. Crude survival of the remaining 174 was 90 % at 3 months, 80% at 6 months, 55% at 1 year, 28% at 2 years, 17% at 3 years, 15O% at 5 years.
Thirteen patients died from intercurrent disease, seven of whom also had residual cancer. Comparison of excision and resection cases: Considering only growths in the upper one-third of the rectum, those excised are compared with those resected. Many of the resected growths were average grade on biopsy, being assessed as high grade only after thorough examination of the operative specimen. Seven Hartmann's operations with resection of the cancer were done as palliation by surgeons interested in this technique.
There were 40 excisions and 32 resections. There was no significant difference in incidence of death from cancer, death from intercurrent disease or five-year survival in the two groups, although the only two operative deaths were in the excision cases. Pelvic recurrence: Many feel that the main aim of palliation is the avoidance of pelvic recurrence. Only those in whom there was significant clinical evidence of such a recurrenceperineal pain and a mass, a definite mass, or severe perineal pain, are considered here. Those with general carcinomatosis who happened to have a pelvic mass are excluded, as they pose a different clinical problem. There were 7 cases of pelvic recurrence but only 3 followed excision of middle or upper third rectal growths; these 3 all died from their cancer in 1, 2, and 2j years respectively. There were no pelvic recurrences in the resection group. This is probably due to the selection of patients for this operation, but we also know that local recurrence is less frequent following upper rectal growths than lower ones. Downward spread: As the extension of radical surgery is only downwards, tumours were specifically examined for microscopic tumour tissue below the visible lower edge of the rectal tumour, either in the bowel wall or in the surrounding tissues. All specimens were meticulously examined by our pathology department.
There were 29 cases in this group, of which only 9 showed downward spread further than 2 cm. All died from their cancer, 11 within six months, 21 within one year; one advanced case with tumour extending downwards 10 cm died from cancer in ten months.
None of the 26 specimens from those patients who survived five years showed any microscopic downward spread.
Conclusions
These cases of rectal cancer provide no objective evidence of beneficial effects from more radical surgery; the increased perineal pain, the longer hospital stay and the frequency of discharge from
